Pharma & Healthcare
Global Acute Agitation and Aggression Drugs Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4115
- Pages: 86
- Figures: 114
- Views: 22
With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas.
Market Analysis and Insights: Global Acute Agitation and Aggression Drugs Market
The global Acute Agitation and Aggression Drugs market is projected to grow from US$ 935 million in 2024 to US$ 1403.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Acute Agitation and Aggression Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Acute Agitation and Aggression Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Acute Agitation and Aggression Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Acute Agitation and Aggression Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Acute Agitation and Aggression Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Acute Agitation and Aggression Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Eli Lilly and Company
Pfizer
Ono Pharmaceutical
Otsuka Holdings
GlaxoSmithKline
Bristol-Myers Squibb
Johnson & Johnson
H. Lundbeck A/S
Segment by Type
Oral
Intramuscular Injection
Others
Segment by Application
Hospitals & Ambulatory Surgical Centers
Psychiatric Care Facilities
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Acute Agitation and Aggression Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Agitation and Aggression Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acute Agitation and Aggression Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Acute Agitation and Aggression Drugs Market
The global Acute Agitation and Aggression Drugs market is projected to grow from US$ 935 million in 2024 to US$ 1403.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Acute Agitation and Aggression Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Acute Agitation and Aggression Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Acute Agitation and Aggression Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Acute Agitation and Aggression Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Acute Agitation and Aggression Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Acute Agitation and Aggression Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Eli Lilly and Company
Pfizer
Ono Pharmaceutical
Otsuka Holdings
GlaxoSmithKline
Bristol-Myers Squibb
Johnson & Johnson
H. Lundbeck A/S
Segment by Type
Oral
Intramuscular Injection
Others
Segment by Application
Hospitals & Ambulatory Surgical Centers
Psychiatric Care Facilities
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Acute Agitation and Aggression Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Agitation and Aggression Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acute Agitation and Aggression Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Intramuscular Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals & Ambulatory Surgical Centers
1.3.3 Psychiatric Care Facilities
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Agitation and Aggression Drugs Market Perspective (2019-2030)
2.2 Global Acute Agitation and Aggression Drugs Growth Trends by Region
2.2.1 Acute Agitation and Aggression Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acute Agitation and Aggression Drugs Historic Market Size by Region (2019-2024)
2.2.3 Acute Agitation and Aggression Drugs Forecasted Market Size by Region (2025-2030)
2.3 Acute Agitation and Aggression Drugs Market Dynamics
2.3.1 Acute Agitation and Aggression Drugs Industry Trends
2.3.2 Acute Agitation and Aggression Drugs Market Drivers
2.3.3 Acute Agitation and Aggression Drugs Market Challenges
2.3.4 Acute Agitation and Aggression Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Acute Agitation and Aggression Drugs by Players
3.1.1 Global Acute Agitation and Aggression Drugs Revenue by Players (2019-2024)
3.1.2 Global Acute Agitation and Aggression Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Acute Agitation and Aggression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Acute Agitation and Aggression Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Acute Agitation and Aggression Drugs Market Concentration Ratio
3.4.1 Global Acute Agitation and Aggression Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Agitation and Aggression Drugs Revenue in 2023
3.5 Global Key Players of Acute Agitation and Aggression Drugs Head office and Area Served
3.6 Global Key Players of Acute Agitation and Aggression Drugs, Product and Application
3.7 Global Key Players of Acute Agitation and Aggression Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Agitation and Aggression Drugs Breakdown Data by Type
4.1 Global Acute Agitation and Aggression Drugs Historic Market Size by Type (2019-2024)
4.2 Global Acute Agitation and Aggression Drugs Forecasted Market Size by Type (2025-2030)
5 Acute Agitation and Aggression Drugs Breakdown Data by Application
5.1 Global Acute Agitation and Aggression Drugs Historic Market Size by Application (2019-2024)
5.2 Global Acute Agitation and Aggression Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acute Agitation and Aggression Drugs Market Size (2019-2030)
6.2 North America Acute Agitation and Aggression Drugs Market Size by Type
6.2.1 North America Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
6.2.2 North America Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
6.2.3 North America Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
6.3 North America Acute Agitation and Aggression Drugs Market Size by Application
6.3.1 North America Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
6.3.2 North America Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
6.3.3 North America Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
6.4 North America Acute Agitation and Aggression Drugs Market Size by Country
6.4.1 North America Acute Agitation and Aggression Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Acute Agitation and Aggression Drugs Market Size by Country (2019-2024)
6.4.3 North America Acute Agitation and Aggression Drugs Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Acute Agitation and Aggression Drugs Market Size (2019-2030)
7.2 Europe Acute Agitation and Aggression Drugs Market Size by Type
7.2.1 Europe Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
7.2.2 Europe Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
7.2.3 Europe Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
7.3 Europe Acute Agitation and Aggression Drugs Market Size by Application
7.3.1 Europe Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
7.3.2 Europe Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
7.3.3 Europe Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
7.4 Europe Acute Agitation and Aggression Drugs Market Size by Country
7.4.1 Europe Acute Agitation and Aggression Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Acute Agitation and Aggression Drugs Market Size by Country (2019-2024)
7.4.3 Europe Acute Agitation and Aggression Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Acute Agitation and Aggression Drugs Market Size (2019-2030)
8.2 China Acute Agitation and Aggression Drugs Market Size by Type
8.2.1 China Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
8.2.2 China Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
8.2.3 China Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
8.3 China Acute Agitation and Aggression Drugs Market Size by Application
8.3.1 China Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
8.3.2 China Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
8.3.3 China Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Acute Agitation and Aggression Drugs Market Size (2019-2030)
9.2 Asia Acute Agitation and Aggression Drugs Market Size by Type
9.2.1 Asia Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
9.2.2 Asia Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
9.2.3 Asia Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
9.3 Asia Acute Agitation and Aggression Drugs Market Size by Application
9.3.1 Asia Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
9.3.2 Asia Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
9.3.3 Asia Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
9.4 Asia Acute Agitation and Aggression Drugs Market Size by Region
9.4.1 Asia Acute Agitation and Aggression Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Acute Agitation and Aggression Drugs Market Size by Region (2019-2024)
9.4.3 Asia Acute Agitation and Aggression Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Acute Agitation and Aggression Drugs Introduction
11.1.4 Eli Lilly and Company Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.1.5 Eli Lilly and Company Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Acute Agitation and Aggression Drugs Introduction
11.2.4 Pfizer Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Ono Pharmaceutical
11.3.1 Ono Pharmaceutical Company Details
11.3.2 Ono Pharmaceutical Business Overview
11.3.3 Ono Pharmaceutical Acute Agitation and Aggression Drugs Introduction
11.3.4 Ono Pharmaceutical Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.3.5 Ono Pharmaceutical Recent Developments
11.4 Otsuka Holdings
11.4.1 Otsuka Holdings Company Details
11.4.2 Otsuka Holdings Business Overview
11.4.3 Otsuka Holdings Acute Agitation and Aggression Drugs Introduction
11.4.4 Otsuka Holdings Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.4.5 Otsuka Holdings Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Acute Agitation and Aggression Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Acute Agitation and Aggression Drugs Introduction
11.6.4 Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Acute Agitation and Aggression Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.7.5 Johnson & Johnson Recent Developments
11.8 H. Lundbeck A/S
11.8.1 H. Lundbeck A/S Company Details
11.8.2 H. Lundbeck A/S Business Overview
11.8.3 H. Lundbeck A/S Acute Agitation and Aggression Drugs Introduction
11.8.4 H. Lundbeck A/S Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.8.5 H. Lundbeck A/S Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Intramuscular Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals & Ambulatory Surgical Centers
1.3.3 Psychiatric Care Facilities
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Agitation and Aggression Drugs Market Perspective (2019-2030)
2.2 Global Acute Agitation and Aggression Drugs Growth Trends by Region
2.2.1 Acute Agitation and Aggression Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acute Agitation and Aggression Drugs Historic Market Size by Region (2019-2024)
2.2.3 Acute Agitation and Aggression Drugs Forecasted Market Size by Region (2025-2030)
2.3 Acute Agitation and Aggression Drugs Market Dynamics
2.3.1 Acute Agitation and Aggression Drugs Industry Trends
2.3.2 Acute Agitation and Aggression Drugs Market Drivers
2.3.3 Acute Agitation and Aggression Drugs Market Challenges
2.3.4 Acute Agitation and Aggression Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Acute Agitation and Aggression Drugs by Players
3.1.1 Global Acute Agitation and Aggression Drugs Revenue by Players (2019-2024)
3.1.2 Global Acute Agitation and Aggression Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Acute Agitation and Aggression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Acute Agitation and Aggression Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Acute Agitation and Aggression Drugs Market Concentration Ratio
3.4.1 Global Acute Agitation and Aggression Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Agitation and Aggression Drugs Revenue in 2023
3.5 Global Key Players of Acute Agitation and Aggression Drugs Head office and Area Served
3.6 Global Key Players of Acute Agitation and Aggression Drugs, Product and Application
3.7 Global Key Players of Acute Agitation and Aggression Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Agitation and Aggression Drugs Breakdown Data by Type
4.1 Global Acute Agitation and Aggression Drugs Historic Market Size by Type (2019-2024)
4.2 Global Acute Agitation and Aggression Drugs Forecasted Market Size by Type (2025-2030)
5 Acute Agitation and Aggression Drugs Breakdown Data by Application
5.1 Global Acute Agitation and Aggression Drugs Historic Market Size by Application (2019-2024)
5.2 Global Acute Agitation and Aggression Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acute Agitation and Aggression Drugs Market Size (2019-2030)
6.2 North America Acute Agitation and Aggression Drugs Market Size by Type
6.2.1 North America Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
6.2.2 North America Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
6.2.3 North America Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
6.3 North America Acute Agitation and Aggression Drugs Market Size by Application
6.3.1 North America Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
6.3.2 North America Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
6.3.3 North America Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
6.4 North America Acute Agitation and Aggression Drugs Market Size by Country
6.4.1 North America Acute Agitation and Aggression Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Acute Agitation and Aggression Drugs Market Size by Country (2019-2024)
6.4.3 North America Acute Agitation and Aggression Drugs Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Acute Agitation and Aggression Drugs Market Size (2019-2030)
7.2 Europe Acute Agitation and Aggression Drugs Market Size by Type
7.2.1 Europe Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
7.2.2 Europe Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
7.2.3 Europe Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
7.3 Europe Acute Agitation and Aggression Drugs Market Size by Application
7.3.1 Europe Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
7.3.2 Europe Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
7.3.3 Europe Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
7.4 Europe Acute Agitation and Aggression Drugs Market Size by Country
7.4.1 Europe Acute Agitation and Aggression Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Acute Agitation and Aggression Drugs Market Size by Country (2019-2024)
7.4.3 Europe Acute Agitation and Aggression Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Acute Agitation and Aggression Drugs Market Size (2019-2030)
8.2 China Acute Agitation and Aggression Drugs Market Size by Type
8.2.1 China Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
8.2.2 China Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
8.2.3 China Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
8.3 China Acute Agitation and Aggression Drugs Market Size by Application
8.3.1 China Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
8.3.2 China Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
8.3.3 China Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Acute Agitation and Aggression Drugs Market Size (2019-2030)
9.2 Asia Acute Agitation and Aggression Drugs Market Size by Type
9.2.1 Asia Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
9.2.2 Asia Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
9.2.3 Asia Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
9.3 Asia Acute Agitation and Aggression Drugs Market Size by Application
9.3.1 Asia Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
9.3.2 Asia Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
9.3.3 Asia Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
9.4 Asia Acute Agitation and Aggression Drugs Market Size by Region
9.4.1 Asia Acute Agitation and Aggression Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Acute Agitation and Aggression Drugs Market Size by Region (2019-2024)
9.4.3 Asia Acute Agitation and Aggression Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Acute Agitation and Aggression Drugs Introduction
11.1.4 Eli Lilly and Company Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.1.5 Eli Lilly and Company Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Acute Agitation and Aggression Drugs Introduction
11.2.4 Pfizer Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Ono Pharmaceutical
11.3.1 Ono Pharmaceutical Company Details
11.3.2 Ono Pharmaceutical Business Overview
11.3.3 Ono Pharmaceutical Acute Agitation and Aggression Drugs Introduction
11.3.4 Ono Pharmaceutical Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.3.5 Ono Pharmaceutical Recent Developments
11.4 Otsuka Holdings
11.4.1 Otsuka Holdings Company Details
11.4.2 Otsuka Holdings Business Overview
11.4.3 Otsuka Holdings Acute Agitation and Aggression Drugs Introduction
11.4.4 Otsuka Holdings Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.4.5 Otsuka Holdings Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Acute Agitation and Aggression Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Acute Agitation and Aggression Drugs Introduction
11.6.4 Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Acute Agitation and Aggression Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.7.5 Johnson & Johnson Recent Developments
11.8 H. Lundbeck A/S
11.8.1 H. Lundbeck A/S Company Details
11.8.2 H. Lundbeck A/S Business Overview
11.8.3 H. Lundbeck A/S Acute Agitation and Aggression Drugs Introduction
11.8.4 H. Lundbeck A/S Revenue in Acute Agitation and Aggression Drugs Business (2019-2024)
11.8.5 H. Lundbeck A/S Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Intramuscular Injection
Table 4. Key Players of Others
Table 5. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Acute Agitation and Aggression Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Acute Agitation and Aggression Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Acute Agitation and Aggression Drugs Market Share by Region (2019-2024)
Table 9. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Acute Agitation and Aggression Drugs Market Share by Region (2025-2030)
Table 11. Acute Agitation and Aggression Drugs Market Trends
Table 12. Acute Agitation and Aggression Drugs Market Drivers
Table 13. Acute Agitation and Aggression Drugs Market Challenges
Table 14. Acute Agitation and Aggression Drugs Market Restraints
Table 15. Global Acute Agitation and Aggression Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Acute Agitation and Aggression Drugs Revenue Share by Players (2019-2024)
Table 17. Global Top Acute Agitation and Aggression Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Agitation and Aggression Drugs as of 2023)
Table 18. Global Acute Agitation and Aggression Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Acute Agitation and Aggression Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Acute Agitation and Aggression Drugs, Headquarters and Area Served
Table 21. Global Key Players of Acute Agitation and Aggression Drugs, Product and Application
Table 22. Global Key Players of Acute Agitation and Aggression Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Acute Agitation and Aggression Drugs Revenue Share by Application (2019-2024)
Table 30. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Acute Agitation and Aggression Drugs Revenue Share by Application (2025-2030)
Table 32. North America Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Acute Agitation and Aggression Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Acute Agitation and Aggression Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Acute Agitation and Aggression Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Acute Agitation and Aggression Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Acute Agitation and Aggression Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Acute Agitation and Aggression Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Acute Agitation and Aggression Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Acute Agitation and Aggression Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Acute Agitation and Aggression Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 64. Eli Lilly and Company Company Details
Table 65. Eli Lilly and Company Business Overview
Table 66. Eli Lilly and Company Acute Agitation and Aggression Drugs Product
Table 67. Eli Lilly and Company Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 68. Eli Lilly and Company Recent Developments
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Acute Agitation and Aggression Drugs Product
Table 72. Pfizer Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 73. Pfizer Recent Developments
Table 74. Ono Pharmaceutical Company Details
Table 75. Ono Pharmaceutical Business Overview
Table 76. Ono Pharmaceutical Acute Agitation and Aggression Drugs Product
Table 77. Ono Pharmaceutical Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 78. Ono Pharmaceutical Recent Developments
Table 79. Otsuka Holdings Company Details
Table 80. Otsuka Holdings Business Overview
Table 81. Otsuka Holdings Acute Agitation and Aggression Drugs Product
Table 82. Otsuka Holdings Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 83. Otsuka Holdings Recent Developments
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Acute Agitation and Aggression Drugs Product
Table 87. GlaxoSmithKline Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 88. GlaxoSmithKline Recent Developments
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Acute Agitation and Aggression Drugs Product
Table 92. Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 93. Bristol-Myers Squibb Recent Developments
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Acute Agitation and Aggression Drugs Product
Table 97. Johnson & Johnson Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 98. Johnson & Johnson Recent Developments
Table 99. H. Lundbeck A/S Company Details
Table 100. H. Lundbeck A/S Business Overview
Table 101. H. Lundbeck A/S Acute Agitation and Aggression Drugs Product
Table 102. H. Lundbeck A/S Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 103. H. Lundbeck A/S Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Acute Agitation and Aggression Drugs Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Intramuscular Injection Features
Figure 5. Others Features
Figure 6. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Acute Agitation and Aggression Drugs Market Share by Application: 2023 VS 2030
Figure 8. Hospitals & Ambulatory Surgical Centers Case Studies
Figure 9. Psychiatric Care Facilities Case Studies
Figure 10. Others Case Studies
Figure 11. Acute Agitation and Aggression Drugs Report Years Considered
Figure 12. Global Acute Agitation and Aggression Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Acute Agitation and Aggression Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Acute Agitation and Aggression Drugs Market Share by Region: 2023 VS 2030
Figure 15. Global Acute Agitation and Aggression Drugs Market Share by Players in 2023
Figure 16. Global Top Acute Agitation and Aggression Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Agitation and Aggression Drugs as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Acute Agitation and Aggression Drugs Revenue in 2023
Figure 18. North America Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 20. North America Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 21. North America Acute Agitation and Aggression Drugs Market Share by Country (2019-2030)
Figure 22. United States Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Acute Agitation and Aggression Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 26. Europe Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 27. Europe Acute Agitation and Aggression Drugs Market Share by Country (2019-2030)
Figure 28. Germany Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Acute Agitation and Aggression Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 36. China Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 37. Asia Acute Agitation and Aggression Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 39. Asia Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 40. Asia Acute Agitation and Aggression Drugs Market Share by Region (2019-2030)
Figure 41. Japan Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Country (2019-2030)
Figure 51. Brazil Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 59. Ono Pharmaceutical Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 60. Otsuka Holdings Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 63. Johnson & Johnson Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 64. H. Lundbeck A/S Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Intramuscular Injection
Table 4. Key Players of Others
Table 5. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Acute Agitation and Aggression Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Acute Agitation and Aggression Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Acute Agitation and Aggression Drugs Market Share by Region (2019-2024)
Table 9. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Acute Agitation and Aggression Drugs Market Share by Region (2025-2030)
Table 11. Acute Agitation and Aggression Drugs Market Trends
Table 12. Acute Agitation and Aggression Drugs Market Drivers
Table 13. Acute Agitation and Aggression Drugs Market Challenges
Table 14. Acute Agitation and Aggression Drugs Market Restraints
Table 15. Global Acute Agitation and Aggression Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Acute Agitation and Aggression Drugs Revenue Share by Players (2019-2024)
Table 17. Global Top Acute Agitation and Aggression Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Agitation and Aggression Drugs as of 2023)
Table 18. Global Acute Agitation and Aggression Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Acute Agitation and Aggression Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Acute Agitation and Aggression Drugs, Headquarters and Area Served
Table 21. Global Key Players of Acute Agitation and Aggression Drugs, Product and Application
Table 22. Global Key Players of Acute Agitation and Aggression Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Acute Agitation and Aggression Drugs Revenue Share by Application (2019-2024)
Table 30. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Acute Agitation and Aggression Drugs Revenue Share by Application (2025-2030)
Table 32. North America Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Acute Agitation and Aggression Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Acute Agitation and Aggression Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Acute Agitation and Aggression Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Acute Agitation and Aggression Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Acute Agitation and Aggression Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Acute Agitation and Aggression Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Acute Agitation and Aggression Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Acute Agitation and Aggression Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Acute Agitation and Aggression Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 64. Eli Lilly and Company Company Details
Table 65. Eli Lilly and Company Business Overview
Table 66. Eli Lilly and Company Acute Agitation and Aggression Drugs Product
Table 67. Eli Lilly and Company Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 68. Eli Lilly and Company Recent Developments
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Acute Agitation and Aggression Drugs Product
Table 72. Pfizer Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 73. Pfizer Recent Developments
Table 74. Ono Pharmaceutical Company Details
Table 75. Ono Pharmaceutical Business Overview
Table 76. Ono Pharmaceutical Acute Agitation and Aggression Drugs Product
Table 77. Ono Pharmaceutical Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 78. Ono Pharmaceutical Recent Developments
Table 79. Otsuka Holdings Company Details
Table 80. Otsuka Holdings Business Overview
Table 81. Otsuka Holdings Acute Agitation and Aggression Drugs Product
Table 82. Otsuka Holdings Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 83. Otsuka Holdings Recent Developments
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Acute Agitation and Aggression Drugs Product
Table 87. GlaxoSmithKline Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 88. GlaxoSmithKline Recent Developments
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Acute Agitation and Aggression Drugs Product
Table 92. Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 93. Bristol-Myers Squibb Recent Developments
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Acute Agitation and Aggression Drugs Product
Table 97. Johnson & Johnson Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 98. Johnson & Johnson Recent Developments
Table 99. H. Lundbeck A/S Company Details
Table 100. H. Lundbeck A/S Business Overview
Table 101. H. Lundbeck A/S Acute Agitation and Aggression Drugs Product
Table 102. H. Lundbeck A/S Revenue in Acute Agitation and Aggression Drugs Business (2019-2024) & (US$ Million)
Table 103. H. Lundbeck A/S Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Acute Agitation and Aggression Drugs Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Intramuscular Injection Features
Figure 5. Others Features
Figure 6. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Acute Agitation and Aggression Drugs Market Share by Application: 2023 VS 2030
Figure 8. Hospitals & Ambulatory Surgical Centers Case Studies
Figure 9. Psychiatric Care Facilities Case Studies
Figure 10. Others Case Studies
Figure 11. Acute Agitation and Aggression Drugs Report Years Considered
Figure 12. Global Acute Agitation and Aggression Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Acute Agitation and Aggression Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Acute Agitation and Aggression Drugs Market Share by Region: 2023 VS 2030
Figure 15. Global Acute Agitation and Aggression Drugs Market Share by Players in 2023
Figure 16. Global Top Acute Agitation and Aggression Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Agitation and Aggression Drugs as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Acute Agitation and Aggression Drugs Revenue in 2023
Figure 18. North America Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 20. North America Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 21. North America Acute Agitation and Aggression Drugs Market Share by Country (2019-2030)
Figure 22. United States Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Acute Agitation and Aggression Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 26. Europe Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 27. Europe Acute Agitation and Aggression Drugs Market Share by Country (2019-2030)
Figure 28. Germany Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Acute Agitation and Aggression Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 36. China Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 37. Asia Acute Agitation and Aggression Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 39. Asia Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 40. Asia Acute Agitation and Aggression Drugs Market Share by Region (2019-2030)
Figure 41. Japan Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Acute Agitation and Aggression Drugs Market Share by Country (2019-2030)
Figure 51. Brazil Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Acute Agitation and Aggression Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 59. Ono Pharmaceutical Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 60. Otsuka Holdings Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 63. Johnson & Johnson Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 64. H. Lundbeck A/S Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232